NCT03406611 - Pegtibatinase As an Enzyme Therapy for Patients with Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (COMPOSE) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 22, 2019

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Homocystinuria

Interventions

DRUG

Pegtibatinase

Pegtibatinase sterile solution for subcutaneous injection

DRUG

Placebo

Normal saline for subcutaneous injection

Trial Locations (8)

Travere Investigational Site, New York

Travere Investigational Site, Philadelphia

Travere Investigational Site, Miami

Travere Investigational Site, Indianapolis

Travere Investigational Site, Aurora

Travere Investigational Site - Virtual Site, Culver City

Travere Investigational Site, Portland

Travere Investigational Site, Boston

All Listed Sponsors

lead

Travere Therapeutics, Inc.

INDUSTRY